Document Detail


Influence of shengmai capsule on recovery of living capacity in patients after myocardial infarction.
MedLine Citation:
PMID:  19802535     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To observe the effect of long-term application of Shengmai Capsule (SMC) on recovery of patients after myocardial infarction. METHODS: A total of 120 myocardial infarction patients were: assigned into two groups. Changes of angina pectoris, electrocardiogram (ECG), living capacity and heart function in patients were observed after 6-month treatment. RESULTS: The total effective rate in alleviating angina: pectoris was 90.0% and that in improving ECG figure was 93.3% in the treatment group, both were significantly higher than those in the control group, 73.4% and 70.0% respectively (P<0.05). The Karnofsky Performance Status scores of heart function were increased and the Activity of Daily Living scores in living capacity decreased in both groups, but the improvements were better in the treatment group (P<0.01 and P<0.05). The parameters of cardiac function, including cardiac output, stroke volume, cardiac index and ejection fraction, were increased in both groups, but the increments in the treatment group were more significant (P<0.01 or P<0.05). CONCLUSION: Long-term application of SMC could effectively prevent and treat angina pectoris, improve the living capacity and accelerate the recovery of heart function in patients after myocardial infarction.
Authors:
Ya-chen Zhang; Rui-ming Chen; Bao-jing Lu; Mei-hua Zhao; Ye-zhi Rong
Related Documents :
21315575 - Heart valve tissue engineering: quo vadis?
21075835 - Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insig...
17853315 - Polish registry of acute coronary syndromes (pl-acs). characteristics, treatments and o...
11730085 - Acute and chronic hemodynamic effects of enhanced external counterpulsation in patients...
24134415 - Two-dimensional speckle tracking-derived strain to distinguish acute coronary syndrome ...
17524755 - Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes.
Publication Detail:
Type:  Journal Article     Date:  2009-10-03
Journal Detail:
Title:  Chinese journal of integrative medicine     Volume:  15     ISSN:  1672-0415     ISO Abbreviation:  Chin J Integr Med     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-05     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101181180     Medline TA:  Chin J Integr Med     Country:  China    
Other Details:
Languages:  eng     Pagination:  333-6     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Xinhua Hospital Affiliated to the Medical College of Shanghai Jiao Tong University, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Electrocardiography
Humans
Karnofsky Performance Status
Medicine, Chinese Traditional*
Myocardial Infarction / physiopathology,  therapy*
Quality of Life*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of shenshao tablet on the quality of life for coronary heart disease patients with stable ang...
Next Document:  Study on the changes of thrombosis-associated factors in patients with coronary heart disease of tur...